| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.93.6.1223 |
| P698 | PubMed publication ID | 8653845 |
| P2093 | author name string | Mohan P | |
| Sys SU | |||
| Brutsaert DL | |||
| Paulus WJ | |||
| P2860 | cites work | Cyclic Nucleotide-dependent Protein Kinases | Q114754864 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1223-1229 | |
| P577 | publication date | 1996-03-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Myocardial contractile response to nitric oxide and cGMP. | |
| P478 | volume | 93 |
| Q73700109 | A prospective study of plasma nitrates following human heart transplantation-relevance to myocardial function |
| Q50992757 | A synthetic cGMP-sensitive gene switch providing Viagra(®)-controlled gene expression in mammalian cells and mice. |
| Q43917399 | Actions of a novel synthetic natriuretic peptide on hemodynamics and ventricular function in the dog. |
| Q47672866 | Alterations of the vascular and the myocardial guanylate cyclase/cGMP-system induced by long-term hypertension in rats |
| Q46061208 | Angiotensin II-induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart. |
| Q43636840 | Anti-adrenergic effects of nitric oxide donor SIN-1 in rat cardiac myocytes |
| Q38670035 | Atorvastatin reduces β-Adrenergic dysfunction in rats with diabetic cardiomyopathy |
| Q43541620 | Beneficial effects of adenosine A(2a) agonist CGS-21680 in infarcted and stunned porcine myocardium |
| Q34332896 | Beneficial effects of nitric oxide on cardiac diastolic function: 'the flip side of the coin'. |
| Q26771999 | Breakthrough in heart failure with preserved ejection fraction: are we there yet? |
| Q55294487 | Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO. |
| Q35035923 | Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity |
| Q26853363 | Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction |
| Q36225149 | Cardiac neurobiology of nitric oxide synthases |
| Q37805473 | Cardiogenic shock: the role of inflammation |
| Q62923934 | Cardiomyocyte-Endothelial Cell Interactions in Cardiac Remodeling and Regeneration |
| Q74570453 | Cardioprotection by activation of NO/cGMP pathway after cardioplegic arrest and 8-hour storage |
| Q47671843 | Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve |
| Q37420916 | Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics |
| Q73689293 | Cyclic GMP-dependent and -independent regulation of MAP kinases by sodium nitroprusside in isolated cardiomyocytes |
| Q73045176 | Differences in the nitric oxide/soluble guanylyl cyclase signalling pathway in the myocardium of neonatal and adult rats |
| Q57097937 | Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure |
| Q61937241 | Efectos del óxido nítrico sobre la función cardíaca |
| Q44009034 | Effect of SIN-1 in rat ventricular myocytes: interference with beta-adrenergic stimulation |
| Q44417708 | Effect of acute nitric oxide synthase inhibition in the modulation of heart rate in rats |
| Q35041454 | Effects of C-type natriuretic peptide on rat cardiac contractility |
| Q42725324 | Effects of the NO donor sodium nitroprusside on oxygen consumption and energetics in rabbit myocardium |
| Q43777080 | Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure |
| Q41252759 | Endocardial endothelial dysfunction and heart failure |
| Q37094196 | Endocardial endothelium is a key determinant of force-frequency relationship in rat ventricular myocardium |
| Q53918654 | Expression of inducible nitric oxide synthase, left ventricular function and remodeling in Dahl salt-sensitive hypertensive rats. |
| Q28361071 | Guanosine 3': 5'-cyclic monophosphate-dependent pathway alterations in ventricular cardiomyocytes of spontaneously hypertensive rats |
| Q47863979 | Guanylyl cyclase inhibition reduces contractility and decreases cGMP and cAMP in isolated rat hearts |
| Q74220974 | Heparin and nonanticoagulant heparin preserve regional myocardial contractility after ischemia-reperfusion injury: role of nitric oxide |
| Q33967356 | Hypoxia-induced left ventricular dysfunction in myoglobin-deficient mice |
| Q45105195 | Impact of surgery on nitric oxide in rats: evidence for activation of inducible nitric oxide synthase |
| Q26782894 | Implications of glial nitric oxide in neurodegenerative diseases |
| Q43917341 | Increased coronary perfusion augments cardiac contractility in the rat through stretch-activated ion channels |
| Q77535879 | Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure |
| Q34481821 | Inhaled nitric oxide in cardiology |
| Q44027030 | Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure |
| Q50526456 | Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts. |
| Q73364304 | Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart |
| Q47638246 | Inotropic effects of ETB receptor stimulation and their modulation by endocardial endothelium, NO, and prostaglandins. |
| Q46606210 | Lack of inotropic effect of nitric oxide on the rat myocardium. |
| Q44637505 | Mechanism of the positive contractile effect of nitric oxide on rat ventricular cardiomyocytes with positive force/frequency relationship |
| Q43799960 | Mechanisms whereby rapid RV pacing causes LV dysfunction: perfusion-contraction matching and NO. |
| Q35037549 | Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. |
| Q42487357 | Modulation of contractility by myocyte-derived arginase in normal and hypertrophied feline myocardium |
| Q34963345 | Myocardial contractile effects of nitric oxide |
| Q43016608 | Myocardial dysfunction in sepsis: no role for NO? |
| Q77925476 | Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema |
| Q38153038 | Nitric Oxide-Induced Calcium Release: Activation of Type 1 Ryanodine Receptor, a Calcium Release Channel, through Non-Enzymatic Post-Translational Modification by Nitric Oxide |
| Q73122913 | Nitric oxide activates skeletal and cardiac ryanodine receptors |
| Q42948599 | Nitric oxide and myocardial function in heart failure: friend or foe? |
| Q48912961 | Nitric oxide effects depend on different mechanisms in different regions of the rat heart. |
| Q46747682 | Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation. |
| Q43773136 | Nitric oxide modulates sympathoexcitatory cardiac-cardiovascular reflexes elicited by bradykinin |
| Q43572797 | Nitric oxide reduces energy supply by direct action on the respiratory chain in isolated cardiomyocytes |
| Q35813373 | Nitric oxide's role in the heart: control of beating or breathing? |
| Q34398226 | Nitric oxide: not just a negative inotrope |
| Q35121823 | Nitric-oxide-mediated regulation of cardiac contractility and stretch responses |
| Q34128772 | Overexpression of cytochrome P450 epoxygenases prevents development of hypertension in spontaneously hypertensive rats by enhancing atrial natriuretic peptide. |
| Q41252697 | Paracrine coronary endothelial modulation of diastolic left ventricular function in man: implications for diastolic heart failure |
| Q73226538 | Peroxynitrite is a positive inotropic agent in atrial and ventricular fibres of the frog heart |
| Q91988023 | Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure |
| Q47200001 | Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling. |
| Q33552229 | Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts |
| Q77060503 | Plasma nitric oxide level in heart failure secondary to left ventricular diastolic dysfunction |
| Q43799965 | Positive and negative effects of nitric oxide on Ca(2+) sparks: influence of beta-adrenergic stimulation |
| Q77921042 | Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart |
| Q41790031 | Positive inotropic effect of exogenous and endogenous NO in hypertrophic rat hearts |
| Q34686759 | Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation |
| Q36435753 | Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols |
| Q43961407 | Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes |
| Q34032413 | Role of myofilaments and calcium handling in left ventricular relaxation |
| Q35090358 | Role of nitric oxide in the pathophysiology of heart failure |
| Q44631216 | S-nitrosothiol detection in isolated perfused rat heart |
| Q59650687 | Short-term hypoxic vasodilation in vivo is mediated by bioactive nitric oxide metabolites, rather than free nitric oxide derived from haemoglobin-mediated nitrite reduction |
| Q24805251 | Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin T |
| Q43191752 | Sildenafil increases the force of right atrial contractions in vitro via the NO-guanylyl cyclase pathway involving β-adrenoceptor linked mechanisms |
| Q36193603 | Sodium nitroprusside induces cell death and cytoskeleton degradation in adult rat cardiomyocytes in vitro: implications for anthracycline-induced cardiotoxicity |
| Q42692854 | Sodium nitroprusside, a NO donor, modifies Ca2+ transport and mechanical properties in frog skeletal muscle |
| Q38012596 | Soluble guanylate cyclase: a potential therapeutic target for heart failure |
| Q27024279 | The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction |
| Q41274664 | The cardiac endothelium: functional morphology, development, and physiology |
| Q77766481 | The effects of perhexiline on the rat coronary vasculature |
| Q44063636 | The inotropic effect of nitric oxide on mammalian papillary muscle is dependent on the level of beta1-adrenergic stimulation |
| Q44542631 | The prostaglandins epoprostenol and iloprost increase left ventricular contractility in vivo |
| Q37276489 | The role of nitric oxide in endotoxin-induced cardiodepression. |
| Q34222988 | The role of nitric oxide in the failing heart |
| Q61843052 | The role of nitric oxide in the regulation of myocardial relaxation and diastolic function |
| Q37144638 | Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress |
| Q37112402 | Treatment of muscle mechanoreflex dysfunction in hypertension: effects of L-arginine dialysis in the nucleus tractus solitarii |
| Q43713879 | Triglycerides impair postischemic recovery in isolated hearts: roles of endothelin-1 and trimetazidine |
| Q36543429 | Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response? |
| Q35087054 | sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling |
| Q42416687 | β(3) Receptors: Role in Cardiometabolic Disorders |
Search more.